TP53 and neoplasm: We found that the decision of tumor cells to undergo EMT or MET in response to hypoxia is mediated by a regulatory network involving HIF1A, p53, miR-34a, and its new targets, IRE1A and XBP-1 (see also Figure 8g for a summary model).